The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension.
about
Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology.The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersHemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityDehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.Sildenafil for pulmonary arterial hypertension: when blue turns into white.Hypoxic upregulation of arginase II in human lung endothelial cellsNitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptorSildenafil, nitric oxide, and acute lung injury: pathophysiology beats pharmacotherapy?Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.Cardiopulmonary effects of chronic administration of the NO synthase inhibitor L-NAME in the chick embryo.Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: an ascending-dose study in healthy male volunteers.CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
P2860
Q24805828-458B2A97-36DE-4E51-8929-0CF47F498ACBQ34060215-757C351E-77FF-43B1-8B18-8DB4FF9C394CQ35590733-F640CC96-9539-4BF4-8D71-C437E3CF9A12Q35750972-B8D95C07-AA70-4BC5-9865-591F2FE23A59Q35946199-6802D147-DE43-4F0C-8C75-FB05C7032B25Q36384658-091E5E83-230F-4C3E-833A-FFFB35381CA0Q36501419-F82883DF-CEA6-4567-80E7-81E95ABB72B4Q36573907-230A237C-BD44-4556-910A-61B4A7B4B45FQ37174204-0D26EFD7-1E77-4F30-9DEF-D75B8DF5CDA3Q37823027-79E0571B-877D-409B-A652-2FDF6C1E59D7Q38386942-A0064A50-4B99-480B-94C6-E5BE3114D6EDQ42575459-52037BD9-EBAC-4145-AC35-E3B304B293E9Q44719310-E5B5667D-BEC2-4980-B1CF-D88263E8F612Q46427835-2AA7C1E6-5A2B-4551-ADB9-ECF9C7FCA82BQ46533614-3F000AB2-35B8-4891-B220-22470351CF57Q46562534-7440F208-41D2-411D-88CD-4C37BFC292EEQ46753467-362B0365-4EE4-456E-BD5A-6AE2B07E2242Q57167791-FDEB8DD4-3A08-44E3-B956-B61D0718EB52
P2860
The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of the NO axis and it ...... lmonary arterial hypertension.
@ast
The role of the NO axis and it ...... lmonary arterial hypertension.
@en
type
label
The role of the NO axis and it ...... lmonary arterial hypertension.
@ast
The role of the NO axis and it ...... lmonary arterial hypertension.
@en
prefLabel
The role of the NO axis and it ...... lmonary arterial hypertension.
@ast
The role of the NO axis and it ...... lmonary arterial hypertension.
@en
P356
P1476
The role of the NO axis and it ...... lmonary arterial hypertension.
@en
P2093
Evangelos D Michelakis
P2888
P356
10.1023/A:1022150819223
P577
2003-01-01T00:00:00Z
P6179
1004171458